Media & Press2019-09-17T16:08:49-04:00

    Bexion Pharmaceuticals, Inc. to Present at the Precision Medicine World Conference (PMWC) 2020

    January 15, 2020|

    FOR IMMEDIATE RELEASE [Covington, KY~ January 15, 2020] Bexion Pharmaceuticals, Inc., a clinical stage biotechnology company focused on developing innovative cures for cancer, announced that Dr. Ray Takigiku, Founder and CEO of the Company will present an overview and recent advancements of its lead compound, BXQ-350 in the Immunotherapy Showcase of the PMWC 2020 conference, ... Read More

      Cincinnati Enquirer: 8 Cincinnati biotech companies with big steps to watch in 2020

      January 1, 2020|

      Excerpt: Cincinnati has become a nurturing place for bright ideas in biotechnology, and 2020 could bring big advancements. The Cincinnati USA Regional Chamber of Commerce estimates the industry contributes more than $3 billion to the area economy. Nearly 800 locations employ more than 13,000 workers who are making average salaries of about $100,000 a ... Read More

        Bexion Pharmaceuticals, Inc. To Present Clinical Data at 2019 NORD Annual Meeting

        September 4, 2019|

        Clinical results support strong safety and tolerability for BXQ-350. Topline results support progression into Phase II studies. FOR IMMEDIATE RELEASE Covington, KY ~ 4 September 2019 Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on rare brain and solid tumors, announced today that it will feature a clinical poster presentation at the National Organization for ... Read More

        All Press